Scott Van Winkle - ICR
Darren Jensen - President, CEO & Director
Steven Fife - CFO
Conference Call Participants
Douglas Lane - Lane Research
William Sutherland - The Benchmark Company
Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Second Fiscal Quarter of 2020 Financial Results. [Operator Instructions]. Hosting today's conference will be Scott Van Winkle with ICR. As a reminder, today's conference is being recorded.
And now I would like to turn the conference over to Mr. Van Winkle. Please go ahead, sir.
Scott Van Winkle
Thank you, Doug, and good afternoon, and welcome to LifeVantage Corporation's conference call to discuss results for the second fiscal quarter of 2020.
On the call today from LifeVantage with prepared remarks are Darren Jensen, Chief Executive Officer; and Steve Fife, Chief Financial Officer.
By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4:05 p.m. Eastern Time. If you have not received the release, it is available on the Investor Relations portion of LifeVantage's website at www.lifevantage.com. This call is being webcast, and a replay will be available on the company's website as well.
Before we begin, we'd like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. These statements are based on current expectations of the company's management and involve inherent risks and uncertainties, including those identified in the Risk Factors section of LifeVantage's most recently filed Forms 10-Q and 10-K.
Please note that during today's call, we will discuss non-GAAP financial measures, including results on an adjusted basis. Management believes these financial measures can facilitate a more complete analysis and greater transparency into LifeVantage's ongoing results of operations, particularly when comparing underlying operating results from period to period. We've included a reconciliation of these non-GAAP measures with today's release.
This call also contains time-sensitive information that is accurate only as of the date of this live broadcast, January 28, 2020. LifeVantage assumes no obligation to update any forward-looking projections that may be made in today's release or call.
Now I will turn the call over to the company's CEO, Darren Jensen.
Thank you, Scott, and good afternoon, everyone. It's my pleasure to discuss our second quarter fiscal 2020 results with you today. We are very pleased with our second quarter growth and profit performance, on track with our 2020 guidance for both revenue and adjusted EBITDA, and are increasing our fiscal 2020 guidance for adjusted earnings per share, which Steve will discuss in a moment.
Our second quarter growth was driven by gains in both the Americas and our Asia/Pacific and Europe regions. In the Americas, our launch of Protandim NAD Synergizer in the United States and Canada, along with the continued execution of our strategic initiatives, were the key contributors to growth. As we discussed last quarter, we have put considerable emphasis, preparation and focus on our launch of Protandim NAD Synergizer, and the results of our efforts are apparent in both our financial results for the second quarter and the trends we're seeing in the brand. Our customers have responded positively to the expansion of our flagship brand, and we believe we have assembled an unparalleled lineup of Protandim product solutions.